Clinical Trial Update: Double Blind, Placebo Controlled Study of Safety and Efficacy of Leronlimab in Patients With "Long" COVID-19 [Phase 2]

View source ↗

Summary

Phase 2 double-blind, placebo-controlled trial evaluating safety and efficacy of leronlimab in patients with long COVID-19 has completed with results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Disease 2019
• Long Covid

Drugs mentioned

• Leronlimab (leronlimab)

Snippet

Sponsor: CytoDyn, Inc. | Conditions: Coronavirus Disease 2019 | Phase 2 | Status: COMPLETED | Results posted: 2024-04-11